Literature DB >> 119353

Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile.

H Stierlin, J W Faigle.   

Abstract

1. Quantitative determinations of unchanged diclofenac and two of its major phenolic metabolites were made by reverse isotope dilution analysis on urine of rat, dog, rhesus monkey, baboon and man and on bile of rat, dog and man. Isotope dilution analysis was performed before and after various methods of enzymic and chemical hydrolysis. 2. The same samples were also analysed by two-dimensional t.l.c. and subsequent autoradiography, to estimate the remaining phenolic metabolites. 3. In contrast to rat, rhesus monkey, baboon and man, which excrete mainly hydroxylated metabolites, the dog does not oxidize diclofenac. Dog urine contained a relatively stable taurine conjugate of diclofenac, and in the bile an ester glucuronide was excreted, which decomposed even in weakly alkaline soln. 4. The unstable ester glucuronide found in dog bile was also demonstrable in rat bile. It presumably hydrolyses in the duodenum, releasing diclofenac which undergoes enterohepatic circulation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 119353     DOI: 10.3109/00498257909042328

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  19 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

2.  Prediction of the effects of genetic polymorphism on the pharmacokinetics of CYP2C9 substrates from in vitro data.

Authors:  Makiko Kusama; Kazuya Maeda; Koji Chiba; Akinori Aoyama; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2008-12-12       Impact factor: 4.200

3.  Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects.

Authors:  Kentarou Ushijima; Shu-ichi Tsuruoka; Hidetoshi Tsuda; Gohki Hasegawa; Yuri Obi; Tae Kaneda; Masaki Takahashi; Tomohiro Maekawa; Tomohiro Sasaki; Taka-aki Koshimizu; Akio Fujimura
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

4.  The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration.

Authors:  J V Willis; D B Jack; M J Kendall; V A John
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

5.  Pharmacokinetics and metabolism of diclofenac sodium in Yucatan miniature pigs.

Authors:  R L Oberle; H Das; S L Wong; K K Chan; R J Sawchuk
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

Review 6.  Nonsteroidal anti-inflammatory agents: species differences in pharmacodynamics.

Authors:  Y Ruckebusch; P L Toutain
Journal:  Vet Res Commun       Date:  1983-12       Impact factor: 2.459

7.  Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients.

Authors:  Thomas G Hammond; Xiaoli Meng; Rosalind E Jenkins; James L Maggs; Anahi Santoyo Castelazo; Sophie L Regan; Stuart N L Bennett; Caroline J Earnshaw; Guruprasad P Aithal; Ira Pande; J Gerry Kenna; Andrew V Stachulski; B Kevin Park; Dominic P Williams
Journal:  J Pharmacol Exp Ther       Date:  2014-06-05       Impact factor: 4.030

8.  Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans.

Authors:  Julia Kirchheiner; Ingolf Meineke; Nadine Steinbach; Christian Meisel; Ivar Roots; Jürgen Brockmöller
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

9.  In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers.

Authors:  X Hui; P G Hewitt; N Poblete; H I Maibach; J Z Shainhouse; R C Wester
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

10.  Pharmacological properties of five diclofenac metabolites identified in human plasma.

Authors:  I Wiesenberg-Boettcher; J Pfeilschifter; A Schweizer; A Sallmann; P Wenk
Journal:  Agents Actions       Date:  1991-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.